Wells Fargo’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
9,582
-17,682
-65% -$2.54M ﹤0.01% 3611
2025
Q4
$3.89M Buy
27,264
+10,937
+67% +$1.47M ﹤0.01% 2912
2025
Q3
$1.96M Buy
16,327
+2,317
+17% +$294K ﹤0.01% 3320
2025
Q2
$1.85M Buy
14,010
+200
+1% +$27.1K ﹤0.01% 3268
2025
Q1
$1.92M Buy
13,810
+267
+2% +$41.4K ﹤0.01% 3191
2024
Q4
$2.1M Buy
13,543
+2,784
+26% +$471K ﹤0.01% 3155
2024
Q3
$1.96M Buy
10,759
+482
+5% +$71.4K ﹤0.01% 3062
2024
Q2
$1.22M Buy
10,277
+8,349
+433% +$878K ﹤0.01% 3372
2024
Q1
$207K Sell
1,928
-109
-5% -$10.8K ﹤0.01% 4452
2023
Q4
$203K Buy
2,037
+1,543
+312% +$151K ﹤0.01% 4456
2023
Q3
$58.8K Sell
494
-2,228
-82% -$332K ﹤0.01% 5096
2023
Q2
$485K Buy
2,722
+106
+4% +$19.4K ﹤0.01% 3965
2023
Q1
$432K Buy
2,616
+421
+19% +$72.4K ﹤0.01% 3946
2022
Q4
$346K Sell
2,195
-296
-12% -$45K ﹤0.01% 3867
2022
Q3
$375K Sell
2,491
-7,754
-76% -$1.29M ﹤0.01% 3873
2022
Q2
$1.68M Sell
10,245
-51,338
-83% -$9.88M ﹤0.01% 2922
2022
Q1
$13.7M Buy
61,583
+24,312
+65% +$5.45M ﹤0.01% 1589
2021
Q4
$8.85M Sell
37,271
-131,849
-78% -$30.8M ﹤0.01% 1974
2021
Q3
$39.5M Buy
169,120
+33,926
+25% +$7.11M 0.01% 1208
2021
Q2
$27.8M Buy
135,194
+12,332
+10% +$2.54M 0.01% 1435
2021
Q1
$25.2M Buy
122,862
+37,231
+43% +$7.86M 0.01% 1481
2020
Q4
$18.4M Buy
85,631
+2,396
+3% +$465K ﹤0.01% 1617
2020
Q3
$15.2M Buy
83,235
+7,298
+10% +$1.37M ﹤0.01% 1591
2020
Q2
$14M Sell
75,937
-300,384
-80% -$59.7M ﹤0.01% 1597
2020
Q1
$75.9M Sell
376,321
-6,092
-2% -$1.17M 0.03% 573
2019
Q4
$71.6M Buy
382,413
+33,828
+10% +$5.82M 0.02% 744
2019
Q3
$55.6M Sell
348,585
-70,304
-17% -$14M 0.02% 850
2019
Q2
$106M Buy
418,889
+122,856
+42% +$28.5M 0.03% 554
2019
Q1
$70.8M Sell
296,033
-101,356
-26% -$24.3M 0.02% 716
2018
Q4
$91.3M Sell
397,389
-110,466
-22% -$27.2M 0.03% 546
2018
Q3
$144M Buy
507,855
+68,347
+16% +$20M 0.04% 450
2018
Q2
$129M Sell
439,508
-17,556
-4% -$4.8M 0.04% 483
2018
Q1
$115M Buy
457,064
+1,065
+0.2% +$250K 0.03% 521
2017
Q4
$98.5M Sell
455,999
-104,757
-19% -$21.2M 0.03% 575
2017
Q3
$104M Buy
560,756
+5,044
+0.9% +$880K 0.03% 535
2017
Q2
$95.9M Buy
555,712
+89,872
+19% +$14.4M 0.03% 562
2017
Q1
$71.1M Buy
465,840
+105,570
+29% +$15.4M 0.02% 679
2016
Q4
$53.1M Buy
360,270
+80,954
+29% +$11.7M 0.02% 805
2016
Q3
$35.3M Buy
279,316
+37,592
+16% +$4.53M 0.01% 938
2016
Q2
$27.3M Buy
241,724
+87,400
+57% +$9.07M 0.01% 1098
2016
Q1
$16.1M Buy
154,324
+105,695
+217% +$10.1M 0.01% 1422
2015
Q4
$5.49M Buy
48,629
+9,511
+24% +$1.05M ﹤0.01% 2258
2015
Q3
$4.28M Sell
39,118
-9,902
-20% -$1.06M ﹤0.01% 2429
2015
Q2
$4.69M Sell
49,020
-147,220
-75% -$13.8M ﹤0.01% 2464
2015
Q1
$18.3M Buy
196,240
+29,597
+18% +$2.59M 0.01% 1396
2014
Q4
$13.6M Sell
166,643
-24,501
-13% -$1.88M 0.01% 1574
2014
Q3
$12.3M Sell
191,144
-6,501
-3% -$398K 0.01% 1604
2014
Q2
$12M Sell
197,645
-6,944
-3% -$410K 0.01% 1675
2014
Q1
$12.3M Buy
204,589
+15,601
+8% +$961K 0.01% 1637
2013
Q4
$12M Buy
188,988
+79,590
+73% +$5.12M 0.01% 1589
2013
Q3
$7.43M Buy
109,398
+1,916
+2% +$137K ﹤0.01% 1889
2013
Q2
$7.75M Buy
+107,482
New +$7.11M ﹤0.01% 1774

Other funds holding ICUI

Wells Fargo's ICUI Position: Q1 2026 in Review

Wells Fargo reduced its ICU Medical (ICUI) stake by 65% in Q1 2026, selling an estimated $2.54M and leaving 9,582 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

Wells Fargo first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $144M in Q3 2018. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Wells Fargo held 9,582 shares of ICU Medical worth $1.24M as of Q1 2026.
  • Wells Fargo sold 17,682 ICU Medical shares in Q1 2026, an estimated $2.54M.
  • ICU Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3611 holding.
  • Wells Fargo first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's ICU Medical position peaked at $144M in Q3 2018.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.